课题基金 / 基金详情

One size fits all: The semi-synthesis of new undecaprenol analogues for the study of multiple undecaprenyl-processing enzymes

One size fits all: The semi-synthesis of new undecaprenol analogues for the study of multiple undecaprenyl-processing enzymes
一刀切:半合成新型十一异戊二烯醇类似物,用于研究多种十一异戊烯基加工酶
批准号:
EP/S015892/1
负责人:
Stephen Cochrane
金额:
$27.5万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

Stephen Cochrane的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Antibacterial resistance is a major threat to human health and there is a pertinent need for new antimicrobial targets. Bacteria produce several glycopolymers that are vital to their survival, including peptidoglycan, which is a key component of the bacterial cell wall required for structural integrity. The bacterial cell wall is targeted by many clinically used antibiotics, such as penicillin and vancomycin. Glycopolymer biosynthesis involves several key glycolipid intermediates, all of which are linked to the cell membrane by the molecule undecaprenol. The enzymes that process undecaprenol-linked biomolecules are hot antibiotic targets, as they are unique to bacteria. However, detailed studies on these enzymes and the high-throughput screening of possible inhibitors has been limited due to the lack of suitable probes to monitor their activity. An understanding of enzyme mechanism is a vital pre-requisite to the rationale design of inhibitors. This project aims to develop new labelled analogues of undecaprenol, which will be used to study several novel antibiotic targets and provide a method for the high-throughput screening of potential antibiotic candidates.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Optimizations of Lipid II Synthesis: An Essential Glycolipid Precursor in Bacterial Cell Wall Synthesis and a Validated Antibiotic Target
脂质 II 合成的优化:细菌细胞壁合成中必需的糖脂前体和经过验证的抗生素靶点
DOI: 10.3762/bxiv.2023.49.v1
发表时间: 2023
期刊:
影响因子: --
作者: [Karak M]
通讯作者: Karak M
Targeting membrane-bound bacterial cell wall precursors: a tried and true antibiotic strategy in nature and the clinic.
靶向膜结合细菌细胞壁前体:自然界和临床中经过验证的真实抗生素策略。
DOI: 10.1039/d3cc01070h
发表时间: 2023
期刊: Chemical communications (Cambridge, England)
影响因子: --
作者: [Buijs NP]
通讯作者: Buijs NP
NEW HOPE - NEW Approaches to Overcome the Problem of Antimicrobial Resistance
  • 批准号:
    EP/Y027728/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $161.85万
  • 财政年份:
    2023
  • 负责人:
    Stephen Cochrane
  • 依托单位:
Interrogating the Nisin:lipid II Interaction: A Chemical Biology Approach
  • 批准号:
    EP/V032860/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $31.05万
  • 财政年份:
    2022
  • 负责人:
    Stephen Cochrane
  • 依托单位:
Synthesis of novel brevicidine and laterocidine analogues active against multi-drug-resistant Gram-negative bacteria
  • 批准号:
    EP/T01783X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $49.87万
  • 财政年份:
    2020
  • 负责人:
    Stephen Cochrane
  • 依托单位:
国内基金
海外基金
VLBI天文输出和实时成图系统
  • 批准号:
    10778721
  • 项目类别:
    联合基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2007
  • 负责人:
    王伟华
  • 依托单位: